These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 7338885

  • 1. Complement fixing properties of antibodies to double-stranded DNA in systemic lupus erythematosus.
    Gharavi AE, Elkon KB, Schifferli JA, Hughes GR.
    J Clin Lab Immunol; 1981 Nov; 6(3):251-5. PubMed ID: 7338885
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Complement fixing antibodies to DS-DNA in systemic lupus erythematosus: a study using the immunofluorescent Crithidia luciliae method.
    Beaulieu A, Quismorio FP, kitridou RC, Friou GJ.
    J Rheumatol; 1979 Nov; 6(4):389-96. PubMed ID: 392093
    [Abstract] [Full Text] [Related]

  • 6. Complement-fixing antibodies to dsDNA detected by the immunofluorescence technique on Crithidia luciliae. A critical appraisal.
    Esparza RH, Swaak T, Aarden L, Smeenk R.
    J Rheumatol; 1985 Dec; 12(6):1109-17. PubMed ID: 3912506
    [Abstract] [Full Text] [Related]

  • 7. Complement-fixing anti--double-stranded DNA with the Crithidia method: a better indicator of active SLE than anti-DNA with the Farr method.
    Huber O, Greenberg ML, Huber J.
    J Lab Clin Med; 1979 Jan; 93(1):32-9. PubMed ID: 366049
    [Abstract] [Full Text] [Related]

  • 8. Systemic lupus erythematosus and the crithidia luciliae immunofluorescent test. A comparative study with an adapted Farr radioimmunoassay.
    Whitehouse IJ, Fehr K, Wagenhäuser FJ.
    Z Rheumatol; 1983 Jan; 42(1):28-35. PubMed ID: 6342296
    [Abstract] [Full Text] [Related]

  • 9. Fixation of complement by anti-F(ab')2 antibodies or ssDNA when added to systemic lupus erythematosus sera.
    Shrier DA, Taniguchi O, Barnett EV.
    J Rheumatol; 1984 Apr; 11(2):182-7. PubMed ID: 6610052
    [Abstract] [Full Text] [Related]

  • 10. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P, Deliyska B, Fünfstück R, Hein G, Herrmann D, Stein G.
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [Abstract] [Full Text] [Related]

  • 11. [Determination of anti dsDNA antibodies by immunofluorescence using Crithidia luciliae. I--Diagnostic and prognostic value in systemic lupus erythematosus. Comparison with the Farr radioimmunoassay].
    Borda-Iriarte O, Meyer O, Cyna J, Haïm T, Ryckewaert A.
    Rev Rhum Mal Osteoartic; 1984 Apr; 51(4):185-91. PubMed ID: 6374861
    [Abstract] [Full Text] [Related]

  • 12. Activation of the alternative complement pathway in systemic lupus erythematosus.
    Wilson MR, Arroyave CM, Nakamura RM, Vaughan JH, Tan EM.
    Clin Exp Immunol; 1976 Oct; 26(1):11-20. PubMed ID: 826360
    [Abstract] [Full Text] [Related]

  • 13. [Anti-DNA determination using Crithidia luciliae. Specificity and clinical usefulness in systemic lupus erythematosus].
    Pena Sagredo JL, Orte Martinez FJ, Sanchez Andrada S, Sampedro Alvarez J, Novo Fernandez MJ, Rodriguez Valverde V.
    Rev Rhum Mal Osteoartic; 1982 Apr; 49(5):345-50. PubMed ID: 7048503
    [Abstract] [Full Text] [Related]

  • 14. Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus.
    Daha MR, Hazevoet HM, Vanes LA.
    Clin Exp Immunol; 1983 Sep; 53(3):541-6. PubMed ID: 6604604
    [Abstract] [Full Text] [Related]

  • 15. Relative importance of C3b inactivator and beta 1H globulin in the modulation of the properdin amplification loop in systemic lupus erythematosus.
    Whaley K, Schur PH, Ruddy S.
    Clin Exp Immunol; 1979 Jun; 36(3):408-14. PubMed ID: 114347
    [Abstract] [Full Text] [Related]

  • 16. Complement activating cryoglobulins in the nephritis of systemic lupus erythematosus.
    Adu D, Williams DG.
    Clin Exp Immunol; 1984 Mar; 55(3):495-501. PubMed ID: 6705265
    [Abstract] [Full Text] [Related]

  • 17. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
    Ross GD, Yount WJ, Walport MJ, Winfield JB, Parker CJ, Fuller CR, Taylor RP, Myones BL, Lachmann PJ.
    J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
    [Abstract] [Full Text] [Related]

  • 18. Serum factors activating the alternative complement pathway in autoimmune disease: description of two different factors from patients with systemic lupus erythematosus.
    Arroyave CM, Wilson MR, Tan EM.
    J Immunol; 1976 Mar; 116(3):821-6. PubMed ID: 815434
    [Abstract] [Full Text] [Related]

  • 19. Clinical significance of anti-nDNA antibodies in ANA-positive systemic lupus erythematosus: comparison of the Farr radioimmunoassay and the Crithidia luciliae immunofluorescent technique.
    Chuan MT, Wu YC, Ang ET, Wang JH, In KL, Lü YC.
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1985 Feb; 18(1):15-24. PubMed ID: 3896689
    [Abstract] [Full Text] [Related]

  • 20. Correlation between the levels of antinuclear antibodies, anti-DNA antibodies, and complement in systemic lupus erythematosus.
    Nguyen CP, Cao VV, Fehér J, Gergely P.
    Acta Med Hung; 1988 Feb; 45(2):145-59. PubMed ID: 3266790
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.